Pular para o conteúdo principal
Ranking Invest

PSNL - Personalis, Inc.

Segmento: HealthcarePersonalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test enabling composite biomarkers for cancer treatment; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction capabilities. The company also provides ACE platform for clinical and therapeutic applications such as neoantigen prediction, biomarker identification, and novel drug target selection. It serves biopharmaceutical customers, universities, non-profits, and government entities. The company has partnership with Mayo Clinic; MapKure, LLC; SpringWorks Therapeutics, Inc.; and Moores Cancer Center. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California.

Análise Ranking Invest

Valuation estimado
-$ 111.95 Mi
Valor de Mercado
$ 1.73 Bi
Desconto (AV)-1646.8%
IVR
-0.06A companhia vale -0,06 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
-0.21O valuation alternativo equivale a -21% do valor de mercado da companhia.
MLL
-0.21O lucro líquido dos controladores em 16 trimestres equivale a -21% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 235.16 Mi

Dívida Líquida

-$ 93.97 Mi

L4T

-$ 107.18 Mi

MM4T

-155.62%

Indicadores Básicos

ROE

-45.58%

Índices de Previsibilidade

Receita Líquida

D0.13

Lucro

B0.24

Margem

B0.23

Índices de Tendência

Receita Líquida

D1.43

Lucro

D1.03

Margem

C1.95

Índices de Endividamento

DIV/PAT

-0.40

DIV/L4T

0.88

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.